Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Depner

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Clinical Trials (London, England)|December 2, 2005
Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis TrialBradley S Dixon, Gerald J Beck, Laura M Dember, et al.
The New England Journal of Medicine|December 20, 2002
Effect of dialysis dose and membrane flux in maintenance hemodialysisGarabed Eknoyan, Gerald J Beck, Alfred K Cheung, et al.
The New England Journal of Medicine|November 25, 2010
In-center hemodialysis six times per week versus three times per week, Glenn M Chertow, Nathan W Levin, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Clinical Trials (London, England)|December 2, 2005
Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis TrialBradley S Dixon, Gerald J Beck, Laura M Dember, et al.
The New England Journal of Medicine|December 20, 2002
Effect of dialysis dose and membrane flux in maintenance hemodialysisGarabed Eknoyan, Gerald J Beck, Alfred K Cheung, et al.
The New England Journal of Medicine|November 25, 2010
In-center hemodialysis six times per week versus three times per week, Glenn M Chertow, Nathan W Levin, et al.
Pageof 5